Publisher
Springer International Publishing
Reference66 articles.
1. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. In: IARC scientific publications, editor. Cancer incidence in five continents, vol. vol. 6. Lyon, France: International Agency for Research on Cancer; 1992.
2. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297–306.
3. Verburg FA, Mader U, Luster M, Reiners C. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases. Eur J Endocrinol. 2009;160:619–24.
4. Verburg FA, Mader U, Tanase K, Thies ED, Diessl S, Buck AK, Luster M, Reiners C. Life expectancy is reduced in differentiated thyroid cancer patients >= 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013;98:172–80.
5. Tanase K, Thies ED, Mader U, Reiners C, Verburg FA. The TNM system (version 7) is the most accurate staging system for the prediction of loss of life expectancy in differentiated thyroid cancer. Clin Endocrinol. 2016;84(2):284–91.